Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanobiosym attracts major business leader to its global advisory board

This article was originally published in Clinica

Executive Summary

Ratan Tata has joined the global advisory board of Nanobiosym, a medical nanotechnology firm based in Medford, Massachusetts. Mr Tata is chairman of the largest private company in India, the multibillion-dollar multinational conglomerate Tata Group (Mumbai, India). “Mr Tata’s example provides us with a practical roadmap for bringing cutting edge technologies into emerging economies and extending our reach to broad markets at the ‘bottom of the pyramid’,” said Anita Goel, the company’s chairman and CEO. The company’s Gene-RADAR technology is a handheld nanotech platform that can rapidly detect genetic fingerprints from any biological organism, from a drop of blood or saliva. It will facilitate patients’ access to information about their health. Alfred Ford, director of the Ford Motor Company, is also a member of the firm’s global advisory board.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT040920

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel